Discover Merit Medical Systems’ Q3 2025 earnings highlights—record margins, revenue growth, and strategic outlook under new CEO leadership.
Discover Stryker's Q3 2025 earnings call insights—organic growth, margin expansion, new acquisitions, and an upbeat outlook.
StockStory.org on MSN
Merit Medical Systems (NASDAQ:MMSI) Delivers Strong Q3 Numbers, Stock Soars
Medical device company Merit Medical Systems (NASDAQ:MMSI) announced in Q3 CY2025, with sales up 13% year on year to $384.2 ...
Reported revenue of $384.2 million, up 13.0% Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 7.8%, respectively GAAP operating margin of 11.1%, compared to 11.0% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results